The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects
Open accessAbstract
In recent years, there has been an exponential increase in the number of p53 mutations identified in human cancers. The p53 mutation database consists of a list of point mutations in thep53 gene of human tumors and cell lines, compiled from the published literature and made available through electronic media. The database is now maintained at the International Agency for Research on Cancer (IARC) and is updated twice a year. The current version contains records on 5091 published mutations and is expected to surpass the 6000 mark in the January 1997 release. The database is available in various formats through the European Bioinformatics Institute (EBI) ftp server at: ftp://ftp.ebi.ac.uk/pub/databases/p53/ or by request from IARC (p53database@iarc.fr) and will be searchable through the SRS system in the near future. This report provides a description of the criteria for inclusion of data and of the current formats, a summary of the relevance ofp53 mutation analysis to clinical and biological questions, and a brief discussion of the prospects for future developments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Self-citationCrystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation
Hollstein, M. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.141 · Cited by 499
Self-citationAguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners
Vahakangas, K. H., Metcalf, R. A., Welsh, J. A., Bennett, W. P., Harris, C. C., Samet, J. M., & Lane, D. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)90866-2 · Cited by 316
Self-citationSRS—an indexing and retrieval tool for flat file data libraries
Etzold, T., & Argos, P. (1993) · Bioinformatics · doi:10.1093/bioinformatics/9.1.49 · Cited by 278
p53 point mutation and survival in colorectal cancer patients.
Goh, H. S., Yao, J. T. D., & Smith, D. R. (1995) · PubMed · Cited by 234
Relationship Between Sunlight Exposure and a Key Genetic Alteration in Basal Cell Carcinoma
Gailani, M. R., Leffell, D. J., Ziegler, A., Gross, E. G., Brash, D. E., & Bale, A. E. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.6.349 · Cited by 204
Ory, K., Legros, Y., Auguin, C., & Soussi, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06656.x · Cited by 163
Self-citationGreenblatt, M. S., Grollman, A. P., & Harris, C. C. (1996) · PubMed · Cited by 117
Self-citationHarris, C. C. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.47 · Cited by 107
Self-citationEffects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.
Forrester, K., Lupold, S. E., Ott, V. L., Chay, C. H., Band, V., Wang, X. W., & Harris, C. C. (1995) · PubMed · Cited by 100
Self-citationDoes a genotoxic carcinogen contribute to human breast cancer?
Biggs, P. J., Warren, W., Venitt, S., & Stratton, M. R. (1993) · Mutagenesis · doi:10.1093/mutage/8.4.275 · Cited by 92
Pattern of p53 Gene Mutations in Breast Cancers of Women of the Midwestern United States
Sommer, S. S., Cunningham, J. M., McGovern, R. M., Saitoh, S., Schroeder, J. J., Wold, L. E., & Kovach, J. S. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.4.246 · Cited by 88
Specific DNA binding by different classes of human p53 mutants.
Rolley, N. J., Butcher, S., & Milner, J. (1995) · PubMed · Cited by 81
Cariello, N. F. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.198 · Cited by 72
Nataraj, A. J., Black, H. S., & Ananthaswamy, H. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7961 · Cited by 66
The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer
Soussi, T. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88756-9 · Cited by 55
Self-citationKrawczak, M., Smith‐Sørensen, B., Schmidtke, J., Kakkar, V. V., Cooper, D. N., & Hovig, E. J. (1995) · Human Mutation · doi:10.1002/humu.1380050107 · Cited by 53
Self-citationCariello, N. F. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.119 · Cited by 23
Cited by
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Gillison, M. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.709 · Cited by 3,101
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
Senescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826
DNA Damage, Mutagenesis and Cancer
Basu, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040970 · Cited by 522
Metadata
- Authors
- Hainaut, P., Soussi, T., Shomer, B., Hollstein, M., Greenblatt, M., Hovig, E., Harris, C. C., & Montesano, R.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-01-01
- Volume
- 25
- Issue
- 1
- Pages
- 151-157
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2098911357
- Cited by
- 298
- References
- 21
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.